CUHK study shows modulation of gut microbiota helps enhance safety and efficacy of COVID-19 vaccine.

FEB 2021


The Faculty of Medicine at The Chinese University of Hong Kong conducted a study to investigate the hypothesis that gut microbiome can impact vaccine response and safety. Early laboratory results suggest the microbiome immunity formula developed by CU Medicine can suppress inflammatory response associated with unwanted adverse events receiving COVID-19 vaccine.